Properties
What is it?
International Nonproprietary Name - TROXERUTIN Active Substance: TROXERUTIN Clinical-Pharmacological Group: Venotonic and angioprotective agent. Composition 1 dragee TROXERUTIN .... 300 mg Excipients: Lactose monohydrate, colloidal silicon dioxide anhydrous, macrogol, magnesium stearate. Gel 2%: In a tube of 40 g - TROXERUTIN .... 800 mg Excipients: Carbomer 940, disodium edetate, benzalkonium chloride, sodium hydroxide, purified water. Indications: Chronic venous insufficiency; Varicose veins and varicose dermatitis; Superficial thrombophlebitis, periphlebitis and phlebothrombosis; Post-thrombotic syndrome; Post-traumatic edema, hematoma; Hemorrhoids; Diabetic retinopathy in complex therapy. Dosage and Administration: Capsules: 2-3 capsules per day during meals, with liquid. Maintenance therapy: 1 capsule for 3-4 weeks. The gel is rubbed into the affected area with light movements until fully absorbed, 2 times a day - morning and evening. If necessary, the gel can be used in the form of compresses. Side Effects: Rarely, with prolonged use, the gel may cause redness and itching of the skin. Contraindications: Hypersensitivity to troxerutin or excipients. Pregnancy and Lactation: Capsules: Not recommended in the first trimester of pregnancy. Gel: There are no contraindications for the use of troxerutin gel in pregnant and lactating women. Special Instructions: ♦ Prolonged use of the gel may cause hypersensitivity. ♦ The use of the preparation in therapeutic doses does not affect the ability to drive vehicles, as well as perform tasks that require high concentration of attention. Overdose: Not described. Drug Interactions: No data on the interaction of troxerutin gel with other drugs. Storage Conditions: The preparation should be stored at a temperature not exceeding 250C.
